Stanford Reverses Cognitive Decline in Alzheimer’s With Brain Metabolism Drug
Neuroscientists at Stanford have linked Alzheimer’s disease to the disruption of brain metabolism via the kynurenine pathway, which is affected by amyloid plaque and tau proteins. Their research has demonstrated…